Vytrus Biotech reported 76% sales growth in Q1 2025, with standout gains in Asia-Pacific (271%) and strong global performance. EBITDA doubled to €1.02 million. Its Exosomic...
Vytrus Biotech will present its Q3 2024 financials live on November 7, revealing record revenue of €4.6 million in the last year. Q3 sales rose by...